Transcatheter Pulmonary Valve in Congenital Heart Disease.
Interv Cardiol Clin
; 13(3): 369-384, 2024 Jul.
Article
de En
| MEDLINE
| ID: mdl-38839170
ABSTRACT
Over the last 2 decades, experience with transcatheter pulmonary valve replacement (TPVR) has grown significantly and has become an effective and reliable way of treating pulmonary valve regurgitation, right ventricular outflow (RVOT) obstruction, and dysfunctional bioprosthetic valves and conduits. With the introduction of self-expanding valves and prestents, dilated native RVOT can be addressed with the transcatheter approach. In this article, the authors review the current practices, technical challenges, and outcomes of TPVR.
Mots clés
Texte intégral:
1
Collection:
01-internacional
Base de données:
MEDLINE
Sujet principal:
Valve du tronc pulmonaire
/
Insuffisance pulmonaire
/
Prothèse valvulaire cardiaque
/
Cathétérisme cardiaque
/
Implantation de valve prothétique cardiaque
/
Cardiopathies congénitales
Limites:
Humans
Langue:
En
Journal:
Interv Cardiol Clin
Année:
2024
Type de document:
Article